𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MAGE-A and NY-ESO-1 expression in cervical cancer: Prognostic factors and effects of chemotherapy

✍ Scribed by Chiara Napoletano; Filippo Bellati; Elisabetta Tarquini; Federica Tomao; Federica Taurino; Giulio Spagnoli; Aurelia Rughetti; Ludovico Muzii; Marianna Nuti; Pierluigi Benedetti Panici

Book ID
113432352
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
380 KB
Volume
198
Category
Article
ISSN
1097-6868

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prognostic value of MAGE-A and NY-ESO-1
Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer
✍ Marija Pastorcic-Grgic; Bozena Sarcevic; Danijel Dosen; Antonio Juretic; Giulio πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 184 KB

## Abstract ## Background The prognostic value of cancer testis antigens in pharyngeal cancer is understudied. ## Methods We recruited 90 patients who were treated for pharyngeal cancer. Monoclonal antibodies 57B and B9.8.1.1 were used for detection of MAGE‐A and NY‐ESO‐1 genes. ## Results MAG

Heterogeneous expression of GAGE, NY-ESO
Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy
✍ Argun Akcakanat; Tatsuo Kanda; Tadashi Tanabe; Shintarou Komukai; Kazuhito Yajim πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 421 KB

## Abstract Cancer/testis antigens (CTAs) elicit immune response in cancer patients and are therefore targets of immunotherapy. Current information on CTA expression is primarily based on mRNA assays and little is known about their expression at the protein level. The objectives of our study are to

Identification of NY-ESO-1, MAGE-1, and
Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma
✍ Matthew A. Kienstra; H. Bryan Neel; Scott E. Strome; Patrick Roche πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 219 KB

## Abstract ## Background. Certain tumor antigens have been identified that stimulate an immune response, thus making them targets for immunotherapy. NY‐ESO‐1, MAGE‐1, and MAGE‐3 are such antigens. This study was undertaken to determine their presence or absence in head and neck squamous cell canc